BioSpace News Archive

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2019 on Thursday, October 24, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

Transcat, Inc. (Nasdaq:TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year 2020 results after the close of financial markets on Tuesday, October 22, 2019.

Health Canada is advising Canadians that Pharm Canada Inc. is recalling all lots of “Passion X” and “Passion Fem” from retail because they contain an undeclared prescription drug ingredient (sildenafil) and may pose serious health risks.

Health Canada is informing consumers of the serious fire and burn risks associated with flame jetting occurrences that may result from the use of certain containers of pourable alcohol-based fuels and certain firepots that use those fuels.

NuSpine Franchise Systems, Inc. has a proven membership-based chiropractic model ready for national expansion.

Cumberland announced today that it has joined forces with Chronicled as a preferred systems integration partner for the San Francisco-based technology company’s MediLedger Project, an initiative that builds blockchain-powered ecosystems and supply chain solutions.

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) today announced that one of its wholly owned subsidiaries presented long-term follow-up data from ILUMYA® (tildrakizumab-asmn) Phase 3 reSURFACE 1 and 2 trials at the 28th European Academy of Dermatology and Venereology Congress (EADV) in Madrid, Spain.

The 2019 National Electrical Contractors Association (NECA) Convention & Trade Show in Las Vegas drew its highest purchasing power to date.

Fauna Bio Inc., a biotechnology company leveraging the science of evolution and comparative genomics to discover new treatments for human diseases, announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant

Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that it will be presenting at the inaugural MicroCap Rodeo Investor Conference in Austin, Texas on Tuesday, October 15 at 9:10 a.m. CDT.